ehave, psychedelic stock review

Adding Ehave (EHVFF) $0.04 to Psychedelic Watch List.

Mental Health and Wellness Incubator Set to Launch Four Initiatives.Trading at Year Low. Launching Clinical Trial With Brain Scientific to Monitor Ketamine...

FDA to Ardelyx: “Give us a Couple More Weeks.” (ARDX) $1.80.

Oh boy, another day, another snag. There goes our Christmas bonus, dang. LIVE QUOTE It's been...

Killer, 44-Page Report on GeoVax (GOVX).

And a Nine-Page Summary Report..Great Weekend Reading. This is one killer report. In fact if we might be so...

SEC Charges TherapeuticsMD (TXMD) $2.80 With Regulation FD Violations

Washington D.C., Aug. 20, 2019 — The Securities and Exchange Commission today charged TherapeuticsMD Inc., a pharmaceutical company headquartered...
biogen, biotech stock review

Biotech’s Turning Up…

Biotech Sector Gains Near 10% in Past Month, After Biogen (BIIB) Reports Breaking News. We keep telling investors...

Pivotal Clinical Trials: Frequently Asked Questions (Sofpromed).

What is a pivotal clinical trial? A pivotal clinical trial is a clinical study seeking...

Preventing Type I Diabetes. Here’s How Provention (PRVB) Works.

Here's How Provention's Treatment Works. Interview With an Actual Provention Bio (PRVB) Clinical Trial Participant.
Biotech Stock Review

Video: Okay, You Tested Positive for Corona, Now What?

https://youtu.be/vN30emwcNS4 Professor Roger Seheult,...

The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same (New York Times).

Summary: MAPS is featured in an article on the front page of today's edition of The New York Times!

Latest article

We’re in Tampa for the Kentucky Derby.

GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!